santa cruz biotechnology, inc.
SCBT Logo

Willkommen!        Produkt(e) im Warenkorb.     Bestellen

OAT (S-19) Antikörper: sc-55733

 |  Datenblatt
  • goat polyclonal IgG, 200µg/ml
  • epitope mapping within an internal region of OAT of human origin
  • recommended for detection of hepatic and renal forms of ornithine aminotransferase of mouse, rat and human origin by ELISA; also reactive with additional species, including equine, canine, bovine, porcine and avian
  • blocking peptide, sc-55733 P
 
Weitere OAT Antikörper ...
 
Bestellinformationen
 
Spezies Gen Gen ID Chromosomaler Locus mRNA (Isoform) Accession # Protein Accession # OMIM™ Nummer
Human OAT 4942 10q26.13 NM_000274 P04181
258870
Maus Oat 18242 7 F3 P29758
n.n.
 
Währung auswählen

 Bestellinformationen
ProduktKatalog #MengePreisAnzahlKaufFavorit
OAT (S-19) sc-55733 200 µg/ml $279
OAT (S-19) P sc-55733 P
(peptide)
100 µg/0.5 ml $61
 siRNA Gen Silencer (Klicken Sie auf den Produktnamen für weitere Informationen.)
ProduktKatalog #MengePreisAnzahlKaufFavorit
OAT siRNA (h) sc-62709 10 µM $258
OAT siRNA (m) sc-62710 10 µM $258
OAT (h)-PR sc-62709-PR 10 µM $23
OAT (m)-PR sc-62710-PR 10 µM $23
 shRNA Plasmide (Klicken Sie auf den Produktnamen für weitere Informationen.)
ProduktKatalog #MengePreisAnzahlKaufFavorit
OAT shRNA Plasmid (h) sc-62709-SH 20 µg $520
OAT shRNA Plasmid (m) sc-62710-SH 20 µg $520
 shRNA Lentivirale Partikel (Klicken Sie auf den Produktnamen für weitere Informationen.)
ProduktKatalog #MengePreisAnzahlKaufFavorit
OAT shRNA (h) Lentiviral Particles sc-62709-V 200 µl $625
OAT shRNA (m) Lentiviral Particles sc-62710-V 200 µl $625

OAT Background Information
OAT (ornithine aminotransferase (mitochondrial), ornithine-oxo-acid aminotransferase) is a 439 amino acid protein encoded by the human gene OAT. OAT belongs to the class III pyridoxal-phosphate-dependent aminotransferase family and is usually found as a homotetramer in the mitochondrion matrix. OAT catalyzes the major catalytic reaction for ornithine. Ornithinemia, presumably due to deficiency of ornithine ketoacid aminotransferase (OAT) has been found in patients with gyrate atrophy of the choroid and retina. The clinical history of gyrate atrophy is usually night blindness that begins in late childhood, accompanied by sharply demarcated circular areas of chorioretinal atrophy. During the second and third decades the areas of atrophy enlarge. The hepatic cleavage product, hepatic OAT, is formed by cleaving a 25 amino acid transit peptide from the N-terminus of the OAT precursor. The renal form is produced by cleaving a 35 amino acid transit peptide from the N-terminus.